Documente Academic
Documente Profesional
Documente Cultură
Clearstate’s study in SEA provides detailed and granular insights on ultrasound placement,
usage and perceptions.
Clearstate’s tracking of the medical devices market in South East Asia reveals that the region’s
ultrasound market reached USD54 million in 2007. The market is set to grow at a slow pace of
3%, reaching USD60million in 2010.
GE leads the market for ultrasounds across the region, followed by Aloka, Toshiba and Philips.
A number of regional brands is increasingly offering low-cost portable black-and-white
ultrasounds, prompting more established players to focus on mid-range and high-end segments.
There is growing demand within these segments (for colour ultrasound systems) due to
narrowing price gap compared to basic black-and-white systems.
Clearstate’s study found approximately 12,250 ultrasound units installed in South East Asia.
Black-and-white ultrasounds are more
B &W Co lo ur common across the region, owing to their
affordability. Colour ultrasounds are more
Vietnam 79% 21% prevalent in the Philippines, compared to
other South East Asian countries.
1
www.clearstate.com
SEA ultrasound database planned
Following the highly successful IVD Gateway, Clearstate will add ultrasound to its pioneering
line of usage and demand pattern databases this year. The ultrasound database will compile
data collected from over 1,500 hospitals in South East Asia, and will include granular
information on unit installation, penetration of key brands by segment, region and unit location.
The large user size of the database (nearly one-third of the relevant universe of facilities) will
need little extrapolation and will accurately reflect real usage and consumption of patient
monitoring devices in South East Asia.
Besides strategic impact, the database’s granularity will enable ultrasound suppliers to track
their market performance vis-à-vis competition over time, and monitor changes in usage and
buying behaviour.
About Clearstate
Clearstate, a niche healthcare consultancy, offers strategic advisory and intelligence services to
help medical devices, healthcare services, pharmaceutical and biotechnology firms understand
their current and potential markets, implement pragmatic and innovative strategies to ultimately
tap into new growth opportunities. Our approach to engagements is centred on thorough
analysis of fact-based intelligence and seasoned understanding of markets, practical strategy
recommendations and implementations. We provide accurate, reliable and comprehensive
intelligence on medical device usage and demand across Asia Pacific. We deliver actual and
up-to-date placement, usage and consumption data for devices, equipment and consumables
found in healthcare and commercial settings.
For more information, please visit Clearstate at www.clearstate.com or call +65 63035030.
2
www.clearstate.com